Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis Academic Article uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • Clarity and guidance is required with regard to the use of direct oral anticoagulants in antiphospholipid syndrome (APS) patients, within the confines of the recent European Medicines Agency recommendations, discrepant recommendations in other international guidelines and the limited evidence base. To address this, the Lupus Anticoagulant/Antiphospholipid Antibodies Scientific and Standardization Committee (SSC) chair and co-chairs together with SSC Control of Anticoagulation members propose guidance for healthcare professionals to help them manage APS patients. Uncertainty in this field will be addressed. This guidance will also serve as a call and focus for research.

authors

  • Zuily, Stéphane
  • Cohen, Hannah
  • Isenberg, David
  • Woller, Scott C
  • Crowther, Mark
  • Dufrost, Virginie
  • Wahl, Denis
  • Doré, Caroline J
  • Cuker, Adam
  • Carrier, Marc
  • Pengo, Vittorio
  • Devreese, Katrien MJ

publication date

  • September 2020